NCEL NewcelX Ltd.

NEUTRAL Impact: 3/10 EFFECT
Horizon weeks Filed May 7, 2026 Processed 1mo ago SEC 9999999995-26-001512
IPO/offering going effective
Latest settled — T+20d
NCEL ▼ -2.47% at T+20d
NEUTRAL call ✗ call lost -2.47% · α vs SPY -5.61% · entry $3.24 → $3.16
Next anchor: T+60d in 7w
Currently $3.23 · -0.31% from $3.24 entry
Entry anchored
May 7, 2026
via day open
T+1d
+3.70%
call +3.70% · α +2.87%
$3.36
settled 5w ago
T+5d
0.00%
call 0.00% · α -1.50%
$3.24
settled 4w ago
T+20d
-2.47%
call -2.47% · α -5.61%
$3.16
settled 8d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

NewcelX Ltd.'s shelf registration statement (File No. 333-290516) became effective on May 6, 2026, allowing the company to offer and sell securities at any time. The $18M market cap micro-cap pharmaceutical company can now raise capital through future takedowns, creating potential dilution overhang for existing shareholders.

Actionable Insight

No immediate trading action is required, but monitor for future prospectus supplements (424B) indicating a firm commitment or at-the-market offering. Any announced offering could pressure the stock given the low market cap.

Key Facts

  • Shelf registration effective May 6, 2026 (SEC File No. 333-290516)
  • Company can sell securities (common stock, preferred, warrants, etc.) in one or more offerings
  • Micro-cap pharmaceutical company with $18M market cap
  • Formerly known as NLS Pharmaceutics Ltd. (name change July 2019)

Financial Impact

Not specified

dilution

Risk Factors

  • Potential dilution from future shelf takedowns
  • Lack of specific offering terms at this stage

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001512
Document: 9999999995-26-001512-index.html9999999995-26-001512
Document: 9999999995-26-001512.txt9999999995-26-001512
8 reports for NCEL
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+20▲ +95.57%Apr 1, 2026
Filters
Rows
Reports for NCEL — sortable, filterable
Type Now
Jun 5, 2026
7d ago
6-K
NEUTRAL ★ 4/10
$3.07 awaiting T+5awaiting T+5$3.23 (+5.21%)
May 27, 2026
17d ago
Press Release
NEUTRAL ★ 5/10
$3.45 $3.32▼ −3.77%▼ −4.98%$3.23 (−6.38%)
May 18, 2026
26d ago
EFFECT
BEARISH ★ 5/10
$3.11 $3.15▼ −1.29%▲ +0.33%$3.23 (−3.86%)
May 7, 2026
5w ago
EFFECT
NEUTRAL ★ 3/10
$3.24 $3.24· 0.00%▼ −1.50%$3.23 (−0.31%)
Apr 30, 2026
6w ago
Press Release
BEARISH ★ 6/10
$4.41 $3.32▲ +24.72%▲ +26.44%$3.23 (+26.76%)
Apr 20, 2026
7w ago
6-K
NEUTRAL ★ 4/10
$2.83 $3.87▲ +36.75%▲ +35.84%$3.23 (+14.13%)
Apr 20, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$2.83 $3.87▲ +36.75%▲ +35.84%$3.23 (+14.13%)
Apr 1, 2026
10w ago
6-K
BULLISH ★ 7/10
$2.26 $2.49▲ +10.42%▲ +6.80%$3.23 (+43.24%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (49h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access